Interviews

Heather Bonome, PharmD, director of Pharmacy Segment at URAC, discusses the standards that illustrate quality in specialty pharmacy.

Kristen L. Marjama, DNP, MSN, FNP-BC, clinical educator with Healthcare Clinic at Walgreens in Fort Lauderdale, Florida, discusses the biggest roadblocks to managing asthma.

Lisa Kroon, PharmD, CDE, professor and department chairperson of clinical pharmacy at University of California, San Francisco, School of Pharmacy, discusses the advantages of community pharmacy-led smoking cessation programs versus other health providers' programs.

Kristen L. Marjama, DNP, MSN, FNP-BC, clinical educator with Healthcare Clinic at Walgreens in Fort Lauderdale, Florida, discusses counseling points for different asthma medication classes.

National Association of Specialty Pharmacy (NASP) Executive Director James E. Smeeding, RPh, MBA, discusses changes ahead for specialty pharmacy patients.

Michael Zeglinski, Vice President of Specialty Pharmacy Operations at BriovaRx, discusses how health care reform has changed specialty pharmacy.

Kimberly Henderson, MD, JD, medical director for the Health Systems Alliance at CVS Health and regional medical director for MinuteClinic, discusses how MinuteClinic enhances COPD management.

Lisa Kroon, PharmD, CDE, professor and department chairperson of clinical pharmacy at University of California, San Francisco, School of Pharmacy, talks about how to prepare community pharmacists to provide both behavioral and pharmacotherapeutic smoking cessation advice.

Doug Long, vice president of industry relations at IMS Health, talks about trends pharmacists should look out for in the future.

Eric A Wright, PharmD, MPH, investigator I for Geisinger Health Research and associate professor at Wilkes University, discusses metrics in care transitions that pharmacists should pay attention to.

Paul Greenall, senior vice president of strategy and business development at McKesson Corporation, discusses how community pharmacies can build new networks of customers.

Doug Long, vice president of industry relations at IMS Health, talks about how the movement toward value-based care in the US health system affects community pharmacy.

Doug Long, vice president of industry relations at IMS Health, talks about which approved or pipeline drugs will be growth drivers in the industry during the next few years.

Bruce A. Berger, PhD, president of Berger Consulting LLC, discusses at what point in the continuum of patient care motivational interviewing is most successful and most critical.

Lisa Kroon, PharmD, CDE, professor and department chairperson of clinical pharmacy at University of California, San Francisco, School of Pharmacy, talks about gaps in pharmacy systems' support of smoking cessation.

Doug Long, vice president of industry relations at IMS Health, talks about how community pharmacies have been impacted by new trends in the industry.

Pat Basu, MD, MBA, chief medical officer of Doctor on Demand, discusses challenges associated with the integration of information technologies into pharmacy practice.

Jon Hamrick, executive vice president, Biotech and Specialty Services at Therigy LLC, discusses how specialty pharmacies can best navigate complex reporting requirements from multiple entities.

Bruce A. Berger, PhD, president of Berger Consulting LLC, discusses how motivational interviewing plays into value-based care.

Doug Long, vice president of industry relations at IMS Health, discusses if health care providers will be hesitant to prescribe biosimilars.

Kimberly Henderson, MD, JD, medical director for the Health Systems Alliance at CVS Health and regional medical director for MinuteClinic, discusses the biggest roadblocks to managing COPD and how pharmacists can help overcome those challenges.

Doug Long, vice president of industry relations at IMS Health, talks about the most significant market trend in the pharmaceutical industry so far in 2015.

Eric A Wright, PharmD, MPH, investigator I for Geisinger Health Research and associate professor at Wilkes University, discusses how new technologies will enhance the ability of a community pharmacist to support medication adherence.

Eric A Wright, PharmD, MPH, investigator I for Geisinger Health Research and associate professor at Wilkes University, discusses how socioeconomic factors affect adherence.

Paul Greenall, senior vice president of strategy and business development at McKesson Corporation, talks about how he sees the role of the pharmacist changing in the next few years.

Pat Basu, MD, MBA, chief medical officer of Doctor on Demand, discusses problems associated with automation in the pharmacy dispensing process.

Amy Grogg, PharmD, senior vice president of Strategy and Commercialization at AmerisourceBergen Specialty Group, discusses the projected ramifications from the launch of biosimilars in the United States.

Bruce A. Berger, PhD, president of Berger Consulting LLC, discusses the barriers pharmacists face in utilizing motivational interviewing techniques.

Eric A Wright, PharmD, MPH, investigator I for Geisinger Health Research and associate professor at Wilkes University, discusses what community pharmacists can do to contribute to improving communication and patient care on transition teams.

Jessica Kerr, PharmD, CDE, and assistant department chair at Southern Illinois University Edwardsville discusses what patients should know about Afrezza.